Symbiox Investment & Trading Co Ltd Stock Price Today (NSE: SYMBIOX)
Fundamental Score
Symbiox Investment & Trading Co Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Symbiox Investment & Trading Co Ltd share price today is ₹1.98, up +0.00% on NSE/BSE as of 17 February 2026. Symbiox Investment & Trading Co Ltd (SYMBIOX) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹8.67 (Cr). The 52-week high for SYMBIOX share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 0.60% and a debt-to-equity ratio of 0.00.
Symbiox Investment & Trading Co Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Symbiox Investment & Trading Co Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Symbiox Investment & Trading Co Share Price: A Risk Analysis
The Other Financial Services sector, beyond traditional banking, is often characterized by high volatility and sensitivity to market sentiment. Analyzing the financial stability of companies within this space requires careful consideration of various factors, including management effectiveness, competitive advantages, and ultimately, profitability. This report analyzes the financial position of Symbiox Investment & Trading Co Ltd, and offers insights into key ratios and market conditions impacting the Symbiox Investment & Trading Co share price.
Currently, the Symbiox Investment & Trading Co share price stands at ₹2.03. A notable observation is the absence of a Price-to-Earnings (PE) ratio, which suggests that the company might not be profitable, or perhaps faces challenges in achieving consistent earnings. The company's Return on Capital Employed (ROCE) stands at a low 0.82%. This ROCE indicates a limited ability to generate profit from its capital investments.
A low ROCE significantly impacts the company's economic moat. A stronger moat implies higher barriers to entry for competitors and increased pricing power. With such a low ROCE, Symbiox Investment & Trading Co Ltd struggles to create a substantial economic moat, making it vulnerable to competitive pressures within the financial services landscape. Comparatively, observing the management quality of a peer like
Sumedha Fiscal Services Ltd, might reveal differences in operational efficiency and capital allocation strategies that explain varying levels of profitability within the same sector. An evaluation of Sumedha Fiscal Services' management's experience and track record versus Symbiox’s leadership may provide further insights.In conclusion, the financial analysis of Symbiox Investment & Trading Co Ltd, reveals potential vulnerabilities due to the low ROCE and absence of a PE ratio. Investors should consider these factors when assessing the company's long-term financial stability. This analysis forms part of a larger 80-parameter fundamental audit, verified by Sweta Mishra. This analysis is observational and is not a recommendation to buy, sell, or hold shares.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Symbiox Investment & Trading Co Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYMBIOX across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Consistent Growth Track Record (21.64% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (56.87% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (56.87% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (0.60%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-0.07%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-81.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-69.33%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-3.17 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (3.33%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Symbiox Investment & Trading Co Ltd Financial Statements
Comprehensive financial data for Symbiox Investment & Trading Co Ltd including income statement, balance sheet and cash flow
About SYMBIOX (Symbiox Investment & Trading Co Ltd)
Symbiox Investment & Trading Co Ltd (SYMBIOX) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Financial Services sector with a current market capitalisation of ₹8.67 (Cr). Symbiox Investment & Trading Co Ltd has delivered a Return on Equity (ROE) of 0.60% and a ROCE of 0.82%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking SYMBIOX share price can monitor key metrics including P/E ratio, promoter holding of 3.33%, and quarterly earnings growth.
Company Details
Key Leadership
SYMBIOX Share Price: Frequently Asked Questions
What is the current share price of Symbiox Investment & Trading Co Ltd (SYMBIOX)?
As of 17 Feb 2026, 10:24 am IST, Symbiox Investment & Trading Co Ltd share price is ₹1.98. The SYMBIOX stock has a market capitalisation of ₹8.67 (Cr) on NSE/BSE.
Is SYMBIOX share price Overvalued or Undervalued?
SYMBIOX share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 30.94x. Based on this relative valuation, the Symbiox Investment & Trading Co Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of SYMBIOX share price?
The 52-week high of SYMBIOX share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Symbiox Investment & Trading Co Ltd share price?
Key factors influencing SYMBIOX share price include quarterly earnings growth (Sales Growth: -69.33%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Symbiox Investment & Trading Co Ltd a good stock for long-term investment?
Symbiox Investment & Trading Co Ltd shows a 5-year Profit Growth of 56.87% and an ROE of 0.60%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in SYMBIOX shares.
How does Symbiox Investment & Trading Co Ltd compare with its industry peers?
Symbiox Investment & Trading Co Ltd competes with major peers in the Other Financial Services. Investors should compare SYMBIOX share price P/E of 0.00x and ROE of 0.60% against the industry averages to determine competitive standing.
What is the P/E ratio of SYMBIOX and what does it mean?
SYMBIOX share price has a P/E ratio of N/Ax compared to the industry average of 30.94x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is SYMBIOX performing according to Bull Run's analysis?
SYMBIOX has a Bull Run fundamental score of 22.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SYMBIOX belong to?
SYMBIOX operates in the Other Financial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Symbiox Investment & Trading Co Ltd share price.
What is Return on Equity (ROE) and why is it important for SYMBIOX?
SYMBIOX has an ROE of 0.60%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Symbiox Investment & Trading Co Ltd generates profits from shareholders capital.
How is SYMBIOX debt-to-equity ratio and what does it indicate?
SYMBIOX has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is SYMBIOX dividend yield and is it a good dividend stock?
SYMBIOX offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Symbiox Investment & Trading Co Ltd shares.
How has SYMBIOX share price grown over the past 5 years?
SYMBIOX has achieved 5-year growth rates of: Sales Growth 21.64%, Profit Growth 56.87%, and EPS Growth 56.87%.
What is the promoter holding in SYMBIOX and why does it matter?
Promoters hold 3.33% of SYMBIOX shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Symbiox Investment & Trading Co Ltd.
What is SYMBIOX market capitalisation category?
SYMBIOX has a market capitalisation of ₹9 crores, placing it in the Small-cap category.
How volatile is SYMBIOX stock?
SYMBIOX has a beta of N/A. A beta > 1 suggests the Symbiox Investment & Trading Co Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SYMBIOX operating profit margin trend?
SYMBIOX has a 5-year average Operating Profit Margin (OPM) of -0.07%, indicating the company's operational efficiency.
How is SYMBIOX quarterly performance?
Recent quarterly performance shows Symbiox Investment & Trading Co Ltd YoY Sales Growth of -69.33% and YoY Profit Growth of -81.82%.
What is the institutional holding pattern in SYMBIOX?
SYMBIOX has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Symbiox Investment & Trading Co Ltd stock.